Why Is Nektar Therapeutics Stock Trading Higher On Wednesday?

benzinga.com/news/health-care/25/06/46101160/why-is-nektar-therapeutics-stock-trading-higher-on-wednesday

Nektar Therapeutics (NASDAQ:NKTR) released on Tuesday statistically significant data from the 16-week induction period of the ongoing Phase 2b REZOLVE-AD study of investigational rezpegaldesleukin.
The trial met its primary endpoint of the mean improvement in Eczema Area and Severity…

This story appeared on benzinga.com, 2025-06-25 17:42:17.
The Entire Business World on a Single Page. Free to Use →